FEGOX
Price
$45.59
Change
-$0.78 (-1.68%)
Updated
Nov 13 closing price
Net Assets
4.95B
FGDCX
Price
$47.17
Change
-$1.16 (-2.40%)
Updated
Nov 13 closing price
Net Assets
3.4B
Interact to see
Advertisement

FEGOX vs FGDCX

Header iconFEGOX vs FGDCX Comparison
Open Charts FEGOX vs FGDCXBanner chart's image
First Eagle Gold C
Price$45.59
Change-$0.78 (-1.68%)
VolumeN/A
Net Assets4.95B
Fidelity Advisor Gold C
Price$47.17
Change-$1.16 (-2.40%)
VolumeN/A
Net Assets3.4B
FEGOX vs FGDCX Comparison Chart in %
View a ticker or compare two or three
VS
FEGOX vs. FGDCX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEGOX is a Buy and FGDCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FEGOX has more cash in the bank: 4.95B vs. FGDCX (3.41B). FEGOX pays higher dividends than FGDCX: FEGOX (2.71) vs FGDCX (1.31). FEGOX was incepted earlier than FGDCX: FEGOX (23 years) vs FGDCX (19 years). FEGOX (1.91) is less costly to investors than FGDCX (1.72). FEGOX is a more actively managed with annual turnover of: 60.97 vs. FGDCX (17.00). FGDCX has a lower initial minimum investment than FEGOX: FGDCX (0) vs FEGOX (2500). FGDCX annual gain was more profitable for investors over the last year : 108.30 vs. FEGOX (95.08). FEGOX return over 5 years is better than : 104.35 vs. FGDCX (76.54).
FEGOXFGDCXFEGOX / FGDCX
Total Expense Ratio1.911.72111%
Annual Report Gross Expense Ratio1.911.72111%
Fund Existence23 years19 years-
Gain YTD103.377114.16791%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.95B3.41B145%
Annual Yield % from dividends2.711.31207%
Returns for 1 year95.08108.3088%
Returns for 3 years144.56148.9897%
Returns for 5 years104.3576.54136%
Returns for 10 years353.32310.45114%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JVAAX39.750.15
+0.38%
JPMorgan Value Advantage A
EGOCX19.780.07
+0.36%
Allspring Large Cap Core C
TRPBX26.630.03
+0.11%
T. Rowe Price Spectrum Moderate Allc Inv
SMUYX10.31N/A
N/A
SEI Multi-Strategy Alternative Y (SIMT)
LYFIX15.51N/A
N/A
AlphaCentric Life Sciences & Hlthcare I